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  The first descriptions of what would today be recognized as 
«viable myocardium» appeared in the 1970s, when it was 
observed that ventricular dysfunction reverted after 
revascularization in some patients with antecedents of acute 
myocardial infarction (AMI). Chatterjee K. et al, 1973. 
  The concept of viability is the opposite of that of 
necrosis, which implies an irreversible alteration in 
contractility. In patients with severe left ventricular 
dysfunction of ischemic origin, revascularization leads to 
improvements in ventricular function, survival and 
prognosis. Such improvements may be due to the 
presence of myocardial viability. Mahrholdt H. et al, 
2002. 
  Simple diagnostic methods such as the electrocardiogram, 
resting echocardiography, and ventriculography are available 
to detect myocardial necrosis. Although such methods are not 
helpful in detecting myocardial viability, even without resorting 
to specific diagnostic techniques, revascularization is known to 
improve survival in 50% of patients with severe left ventricular 
dysfunction of ischemic origin. Hayat S.A. et al, 2006. 
  Assessing myocardial viability poses two difficulties. In the 
first place,    viability is not a dichotomous concept, as there are 
degrees of viability ranging from complete absence to total 
normality. In the second place, the lack of a standard reference 
model means that precise assessment of myocardial viability is 
not possible at present, so that results obtained with current 
assessment methods may be open to discussion. La Canna GL. 
et al, 2000.  
  Identifying myocardial hibernation is of clinical relevance, as it 
represents potentially salvageable myocardial tissue. Coronary 
revascularization in this context is likely to improve contractile 
performance, LV systolic function, and, in turn, overall 
morbidity and mortality. However, hibernating myocardium, if 
left untreated, has the potential to transform into clinically 
overt heart failure. Revascularization, via either percutaneous 
angioplasty or coronary bypass surgery, is the primary avenue 
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of restoring coronary blood flow, unless natural collaterals are 
formed from the primary diseased vessel. Ling L.H. et al,2006.  
 
  Dobutamine stress echocardiography (DSE) is used to assess 
myocardial contractile reserve. Low-dose dobutamine (5 to 10 
μg/kg−1 /min−1) can lead to increased contractility in 
dysfunctional segments that are viable. Myocardial contrast 
echocardiography is another tool to determine viability 
through using acoustically active gas-filled micro-bubbles as 
contrast agent that have a diameter smaller than red blood cells 
and remain confined within the intravascular space. Single-
photon emission computed tomography (SPECT) is a widely 
available modality with well-established clinical and prognostic 
validation. Baer FM. et al, 2000.  
 
    Early studies demonstrated that myocardial ischemia and 
infarction could be distinguished by analysis of positron 
emission tomography (PET) images of the perfusion tracer. The 
uptake of FDG by the myocardium and scan quality depend on 
many factors such as dietary state, cardiac workload, 
sympathetic drive, and the presence and severity of ischemia. 
Duncan BH. et al, 2000.  
 
   Cine imaging with gradient echo sequences provides 
information on global LV function, regional wall motion, and 
thickening. An important advance has been the application of 
gadolinium-chelated contrast agents to detect perfusion 
defects, microvascular obstruction, and areas of scarred 
tissue/fibrosis. This technique allows assessment of the 
transmurality of necrosis. The transmural extent of infarction 
correlates with the likelihood of functional recovery of 
dysfunctional myocardium after revascularization. 
Selvanayagam et al, 2006. 
 
   Two-dimensional (2D) speckle-tracking echocardiography is a 
novel ultrasound method used to assess myocardial 
deformation parameters derived from standard 2D grayscale 
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images. Two-dimensional speckle-tracking echocardiography 
has only been used in a few studies for its diagnostic and 
prognostic utility in studying myocardial ischemia and viability. 
Becker M.  et al, 2008. 
 
     Previous studies demonstrated that echocardiographic strain   
  imaging has the potential to discriminate between viable and   
  nonviable tissue. Becker M.  et al, 2006. 
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Aim of work 
 
 
 
 
 
    To evaluate global and regional myocardial function and 
viability in patients with ST elevated myocardial infarction after 
successful revascularization through primary PCI using stress 
speckle tracking echocardiography in comparison to cardiac MRI 
in order to: 
 
1. Assess the feasibility and accuracy of stress speckle 
tracking to risk stratify STEMI patients after 
revascularization. 
 
2. Evaluation of stress speckle tracking in detection of 
functional recovery and viability of global and 
regional myocardial function following successful 
revascularization in STEMI patients. 
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1. Myocardial infarction 
 
  Myocardial infarction, commonly known as a heart attack, is the 
irreversible necrosis of heart muscle secondary to prolonged 
ischemia. This usually results from an imbalance in oxygen 
supply and demand, which is most often caused by plaque 
rupture with thrombus formation in a coronary vessel, resulting 
in an acute reduction of blood supply to a portion of the 
myocardium. McManus DD. et al, 2011. 
 
  The new universal definition clarified that a myocardial 
infarction should be diagnosed by  detection of rise and/or fall of 
cardiac biomarker values (preferably troponin) with at least one 
value above the 99th percentile of the upper reference limit and 
with at least one of the following: Symptoms of ischemia; New or 
presumably new significant ST-T changes or new LBBB; 
Development of pathological Q waves in the ECG;  Imaging 
evidence of new loss of viable myocardium, or new regional wall 
motion abnormality; Identification of an intracoronary thrombus 
by angiography or  autopsy.  Steg PG. et al, 2012. 
 
   Cardiac death with symptoms suggestive of myocardial 
ischemia, and presumably new ECG changes or new LBBB, but 
death occurring before blood cardiac biomarkers values are 
released or before cardiac biomarker values would be increased. 
Stent thrombosis associated with MI when detected by coronary 
angiography or autopsy in the setting of myocardial ischemia 
and with a rise and/or fall of cardiac biomarker values. 
Thygesen K. et al, 2007 
 
Epidemiology 
 
  Ischemic heart disease is the leading cause of death worldwide. 
Cardiovascular diseases cause 12 million deaths throughout the 
world each year, according to the third monitoring report of the 
World Health Organization. They cause half of all deaths in 
several industrialized countries and are one of the main causes 
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of death in many developing countries; they are the major cause 
of death in adults everywhere. Mendis S. et al, 2011.  
 
  Of particular concern are projections from the World Heart 
Federation that the burden of atherosclerotic cardiovascular 
disease in developing countries will increasingly become 
commensurate with that seen in industrialized countries. With a 
decline in infectious disease-related deaths, in conjunction with 
accelerated economic development and life-style changes that 
promote atherosclerosis, rates of ischemic heart disease and 
myocardial infarction are expected to sharply increase in 
developing countries, especially such countries in Eastern 
Europe, Asia, and parts of Latin America. Go AS. et al, 2013. 
 
  According to the WHO, 17.3 million deaths in 2008 were 
attributable to cardiovascular disease, with 7.3 million (42% of 
all cardiovascular deaths) being due the result of a myocardial 
infarction (Figure 1). Mendis S. et al, 2011. 
 
 
 
 
Figure 1. Prevalence of different forms of cardiac diseases in men and women.  
Mendis S. et al, 2011.    
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  The incidence of cardiovascular disease increases with age, with 
acute myocardial infarction being rare in childhood and 
adolescence. Most patients who develop an acute myocardial 
infarction are older than 60 years. Elderly people also tend to 
have higher rates of morbidity and mortality from their infarcts. 
Age (≥75 y) is the strongest predictor of 90-day mortality in 
patients with STEMI undergoing percutaneous coronary 
intervention. A continued focus on improving outcomes for these 
high-risk patients is needed. Gharacholou SM. et al, 2011. 
 
Pathology of STEMI 
 
  Atherosclerosis is a chronic vascular disease that is 
characterized by endothelial dysfunction, intimal hyperplasia, 
inflammation, smooth muscle proliferation, and deposition of 
lipids and formation of microvessels within the vascular wall. 
The focal nature of atherosclerosis results in formation of 
discrete plaques. Key components of the plaque include a fibrous 
cap, composed of smooth muscle cells and fibroblasts, an 
overlying layer of endothelial cells, and an internal core that 
contains cholesterol and other lipids, macrophages, foam cells 
(which are derived from macrophages), other inflammatory 
cells, and extracellular matrix (Figure 2). Kumar et al, 2011. 
 
Figure 2. Pathology of plaque formation and rupture. Kumar et al, 2011. 
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   Some plaques are more vulnerable to rupture than others. 
Important characteristics of the vulnerable plaque include a thin 
fibrous cap, a large, lipid-rich, hypocellular core, and the 
presence of leukocytes, which produce metalloproteinases 
(MMPs) and other factors that trigger extracellular matrix 
degradation and apoptosis, within the fibrous-cap. Sharma M. et 
al, 1997 
 
   Platelets play a central role in the development of thrombi and 
subsequent ischemic events, and this process of platelet-
mediated thrombus formation involves adhesion, activation, and 
aggregation.  Plaque rupture exposes subendothelial collagen, a 
highly thrombogenic material, which serves as a site of plate -let 
adhesion, activation, and aggregation.  Activated platelets 
undergo a series of steps including:  shape change, adhesion to 
endothelial cells of vessels, aggregation, and the secretion of 
granules that perpetuate the cycle (figure 3). Savi P. et al, 1996. 
 
 
 
 
Figure 3. 
Triggers of 
plaque rupture. 
Savi P. et al, 
1996. 
 
   
 
 
 
 
 
 
  An adhesive glycoprotein, von Willebrand factor (vWF), allows 
platelets to stay attached to the subendothelial vessel wall (via 
GP Ib) despite high shear forces.  Following adhesion, platelets 
are activated to secrete a variety  of  agonists  which  are  pro-
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aggregatory  molecules, such  as  thrombin,  serotonin,  
adenosine  diphosphate  (ADP), and thromboxane A(TXA)(Figure 
4).  These agonists, which further augment the platelet activation 
process, bind to specific receptor sites on the platelets to activate 
the GP IIb/IIIa receptor complex, the final common pathway to 
platelet aggregation. Once activated, the GP IIb/IIIa receptor 
undergoes a conformational change that enables it to bind with 
fibrinogen. Born GV. et al, 1970. 
 
 
 
 
Figure 4 : The disruption of an atherosclerotic plaque results in exposure of 
highly thrombogenic material.  In patients with atherothrombosis, the 
activation of platelets and coagulation are inseparable, reciprocally self-
amplifying processes.  The inhibition of platelets alone does not block the 
coagulation activators.  GP denotes glycoprotein, ADP adenosine diphosphate, 
and COX-1 cyclooxygenase-1.  Mohler E.R. et al, 2007. 
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Factors leading to myocardial infarction  
 
Table 1. Causes of Myocardial Infarction without coronary 
atherosclerosis 
Coronary Artery Disease Other than Atherosclerosis 
   
 Arteritis  
    
 
    Granulomatous (Takayasu disease)  
    Polyarteritis nodosa  
    Mucocutaneous lymph node (Kawasaki) syndrome  
    Disseminated lupus erythematosus  
    Rheumatoid spondylitis  
    Ankylosing spondylitis  
 
 
   
 Trauma to coronary arteries  
    Laceration  
    Thrombosis  
    Iatrogenic  
    Radiation (radiation therapy for neoplasia)  
 
 
   
 Coronary mural thickening with metabolic disease or 
intimal proliferative disease  
    Mucopolysaccharidoses (Hurler disease)  
    Homocystinuria  
    Fabry’s disease  
    Amyloidosis  
   
 Juvenile intimal sclerosis (idiopathic arterial 
calcification of infancy)  
   
 Intimal hyperplasia associated with contraceptive 
steroids or with the postpartum period  
    Pseudoxanthoma elasticum  
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    Coronary fibrosis caused by radiation therapy  
 
 
   
 Luminal narrowing by other mechanisms  
   
 Spasm of coronary arteries (Prinzmetal angina with 
normal coronary arteries)  
    Spasm after nitroglycerin withdrawal  
    Dissection of the aorta  
    Dissection of the coronary artery  
 
 
Emboli to Coronary Arteries 
    Infective endocarditis  
    Nonbacterial thrombotic endocarditis  
   
 Papillary fibroelastoma of the aortic valve (“fixed 
embolus”)  
    Thrombi from intracardiac catheters or guidewires  
 
 
 
Pathophysiology of STEMI 
 
Left Ventricular Function  
 
Systolic Function  
  Upon interruption of antegrade flow in an epicardial coronary 
artery, the zone of myocardium supplied by that vessel 
immediately loses its ability to shorten and perform contractile 
work. Four abnormal contraction patterns develop in sequence: 
(1) dyssynchrony, that is, dissociation in the time course of 
contraction of adjacent segments; (2) hypokinesis, reduction in 
the extent of shortening; (3) akinesis, cessation of shortening; 
and (4) dyskinesis, paradoxical expansion, and systolic bulging . 
Schuster EH. et al, 1980 
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Figure 5. Consequences of Myocardial Infarction. Chaudhry et al, 
2005 
   Increased motion of the non-infarcted region subsides within 2 
weeks of infarction, during which time some degree of recovery 
often occurs in the infarct region as well, particularly if 
reperfusion of the infarcted area occurs and myocardial stunning 
diminishes. White HD. et al, 1987  
  If a sufficient quantity of myocardium undergoes ischemic 
injury (Figure 5), left ventricular pump function becomes 
depressed; cardiac output, stroke volume, blood pressure, and 
peak dP/dt decline and end-systolic volume increases. 
Sadanandan S. et al, 2001 
  As necrotic myocytes slip past each other, the infarct zone thins 
and elongates, especially in patients with large anterior infarcts, 
leading to infarct expansion. As the ventricle dilates during the 
first few hours to days after infarction, regional and global wall 
stress increase according to Laplace's law. The degree of 
ventricular dilation, which depends closely on infarct size, 
patency of the infarct-related artery and activation of the renin-
angiotensin-aldosterone system (RAAS), can be favorably 
modified by inhibitors of this system, even in the absence of 
symptomatic left ventricular dysfunction. McMurray J. et al, 
2006 
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   The likelihood of developing clinical symptoms such as 
dyspnea and ultimately a shock-like state correlate with specific 
parameters of left ventricular function. The earliest abnormality 
is a ventricular stiffness in diastole, which can be observed with 
infarcts that involve only a small portion of the left ventricle on 
angiographic examination. When the abnormally contracting 
segment exceeds 15 percent, the ejection fraction may decline 
and elevations of left ventricular end-diastolic pressure and 
volume occur. Hochman JS. et al, 2003 
  Clinical heart failure accompanies areas of abnormal 
contraction exceeding 25 percent, and cardiogenic shock, often 
fatal, accompanies loss of more than 40 percent of the left 
ventricular myocardium. Unless infarct extension occurs, some 
improvement in wall motion takes place during the healing 
phase, as recovery of function occurs in initially reversibly 
injured (stunned) myocardium. Pitt B. et al, 2005 
   
Diastolic Function  
   The diastolic properties of the left ventricle change in infarcted 
and ischemic myocardium. These alterations associate with a 
decrease in the peak rate of decline in left ventricular pressure , 
an increase in the time constant of the fall in left ventricular 
pressure, and an initial rise in left ventricular end-diastolic 
pressure. As with impairment of systolic function, the magnitude 
of the diastolic abnormality appears to relate to the size of the 
infarct. Mads J. Andersen et al, 2013  
 
Ventricular Remodeling  
  As a consequence of STEMI, the changes in left ventricular size, 
shape, and thickness involving both the infarcted and the non-
infarcted segments of the ventricle described earlier occur and 
are collectively referred to as ventricular remodeling, which can 
in turn influence ventricular function and prognosis. A 
combination of changes in left ventricular dilation and 
hypertrophy of residual non-infarcted myocardium causes 
remodeling. Guo X. et al, 2005 
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Clinical Features of STEMI 
 
PRODROMAL SYMPTOMS  
  The patient's history remains crucial to establishing a diagnosis. 
The prodrome is usually characterized by chest discomfort, 
resembling classic angina pectoris, but it occurs at rest or with 
less activity than usual and can therefore be classified as 
unstable angina. Brener SJ. et al, 2006  
 
NATURE OF PAIN 
   The pain of STEMI varies in intensity; in most patients, it is 
severe and in some instances intolerable. The pain is prolonged, 
usually lasting for more than 30 minutes and frequently for a 
number of hours. The discomfort is described as constricting, 
crushing, oppressing, or compressing; often the patient 
complains of a sensation of a heavy weight or a squeezing in the 
chest. Although the discomfort is typically described as a 
choking, viselike, or heavy pain, it can also be characterized as a 
stabbing, knifelike, boring, or burning discomfort. The pain is 
usually retrosternal in location, spreading frequently to both 
sides of the anterior chest, with predilection for the left side. 
Singh JP. et al, 2003 
   Some patients note only a dull ache or numbness of the wrists 
in association with severe substernal or precordial discomfort. In 
other patients, the discomfort of STEMI radiates to the shoulders, 
upper extremities, neck, jaw, and interscapular region, again 
usually favoring the left side. In patients with preexisting angina 
pectoris, the pain of infarction usually resembles that of angina 
with respect to location. However, it is generally much more 
severe, lasts longer, and is not relieved by rest and nitroglycerin. 
Gregoratos G. et al, 2001 
 
SILENT STEMI AND ATYPICAL PRESENTATION 
   Nonfatal STEMI can be unrecognized by the patient and 
discovered only on subsequent routine electrocardiographic or 
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postmortem examinations. Of these unrecognized infarctions, 
approximately half are truly silent, with the patients unable to 
recall any symptoms whatsoever. The other half of patients with 
so-called silent infarction can recall an event characterized by 
symptoms compatible with acute infarction when leading 
questions are posed after the electrocardiographic abnormalities 
are discovered. Unrecognized or silent infarction occurs more 
commonly in patients without antecedent angina pectoris and in 
patients with diabetes and hypertension. Davis TM. et al, 2004 
   Atypical presentations of STEMI include the following:  
(1) heart failure (i.e., dyspnea without pain beginning de novo or 
worsening of established failure) 
 (2) classic angina pectoris without a particularly severe or 
prolonged episode 
 (3) atypical location of the pain 
 (4) central nervous system manifestations, resembling those of 
stroke, secondary to a sharp reduction in cardiac output in a 
patient with cerebral arteriosclerosis 
 (5) apprehension and nervousness 
 (6) sudden mania or psychosis 
 (7) syncope 
 (8) overwhelming weakness 
 (9) acute indigestion 
 (10) peripheral embolization. Davis TM. et al, 2004 
 
 
Laboratory Findings  
 
Serum Markers of Cardiac Damage  
   Necrosis compromises the integrity of the sarcolemmal 
membrane that is compromised and intracellular 
macromolecules (serum cardiac markers) begin to diffuse into 
the cardiac interstitium and ultimately into the microvasculature 
and lymphatics in the region of the infarct ( figure 6).The rate of 
appearance of these macromolecules in the peripheral 
circulation depends on several factors including intracellular 
location, molecular weight, local blood and lymphatic flow, and 
the rate of elimination from the blood. Jaffe AS. et al, 2006 
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Figure 6: The zone of necrosing myocardium is shown at the top of the figure, followed 
in the middle portion of the figure by a diagram of a cardiomyocyte that is in the 
process of releasing biomarkers. Cardiac troponin levels rise to about 20 to 50 times 
the upper reference limit (the 99th percentile of values in a reference control group) in 
patients who have a “classic” acute myocardial infarction (MI) and sustain sufficient 
myocardial necrosis to result in abnormally elevated levels of the MB fraction of 
creatine kinase (CK-MB). Clinicians can now diagnose episodes of micro-infarction by 
sensitive assays that detect cardiac troponin elevations above the upper reference 
limit, even though CK-MB levels may still be in the normal reference range (not 
shown). CV = coefficient of variation.  Jaffe AS. et al, 2006 
 
CREATINE KINASE ISOENZYMES 
   Three isoenzymes of CK exist (MM, BB, and MB). Extracts of 
brain and kidney contain predominantly the BB isoenzyme; 
skeletal muscle contains principally MM but does contain some 
MB (1 to 3 percent); and cardiac muscle contains both MM and 
MB isoenzymes. Although small quantities of CK-MB isoenzyme 
occur in tissues other than the heart, elevated levels of CK-MB 
may be considered, for practical purposes, to be the result of MI 
(except in the case of trauma or surgery). Roger VL. et al, 2006 
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MYOGLOBIN 
   This monomeric protein is released into the circulation from 
injured myocardial cells and can be detected within a few hours 
after the onset of. Peak levels of serum myoglobin are reached 
considerably earlier (1 to 4 hours) than peak values of serum CK. 
Because of its lack of cardiac specificity, an isolated 
measurement of myoglobin within the first 4 to 8 hours after the 
onset of chest discomfort in patients with a non-diagnostic ECG 
should not be relied on to make the diagnosis of MI. Roger VL. et 
al, 2006 
 
CARDIAC-SPECIFIC TROPONINS 
   Although both TnT and TnI are present in cardiac and skeletal 
muscle, they are encoded by different genes and their amino acid 
sequence differs. This permits the production of antibodies that 
are specific for the cardiac form (cTnT and cTnI) and has led to 
the development of quantitative assays for cTnT and cTnI that 
have been approved for clinical use. Several studies have 
confirmed the reliability of these new quantitative assays for 
detecting myocardial injury, and measurement of cTnT or cTnI is 
now at the of the new diagnostic criteria for MI. Apple FS. et al, 
2003 
Diagnosis of STEMI 
Electrocardiography  
    The ECG is the most useful and feasible diagnostic tool for the 
initial evaluation, early risk stratification, triage, and guidance of 
therapy in patients who have chest pain. There is currently a 
growing trend for 12-lead ECGs to be recorded in the field by 
paramedics and transmitted by cellular telephone or fax to the 
target emergency department. It is conceivable that emergency 
department physicians will be involved in triaging patients in the 
prehospital phase to hospitals offering primary percutaneous 
coronary intervention (PCI), which is now recognized to be a 
superior reperfusion strategy than thrombolytic therapy. Keeley 
et al,2003 
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   Some of the patients who have acute chest pain and ST 
elevation may subsequently have an increase in cardiac markers 
without any further ECG changes (no ST resolution, no new Q-
wave development, and no T-wave inversion). These patients 
may have non-STEMI with baseline ST elevation, or pseudo 
STEMI, On the other hand, there are patients who have transient 
ST elevation who have ST resolution without an increase in the 
cardiac markers. Although some of them may have acute 
pericarditis, Prinzmetal angina, or aborted myocardial infarction, 
many simply have transient early repolarization. Dowdy L. et al, 
2004 
ECG changes during the acute phase of ST-elevation myocardial 
infarction 
    Shortly after occlusion of a coronary artery, serial ECG changes 
are detected by leads facing the ischemic zone, as shown in Fig. 2. 
First, the T waves become tall, symmetrical, and peaked (grade 1 
ischemia); second, there is ST elevation (grade 2 ischemia) 
without distortion of the terminal portion of the QRS; and third, 
changes in the terminal portion of the QRS complex may appear 
(grade 3 ischemia). The changes in the terminal portion of the 
QRS are explained by prolongation of the electrical conduction in 
the Purkinje fibers in the ischemic region. The delayed 
conduction decreases the degree of cancellation resulting in an 
increase in R-wave amplitude in leads with terminal R wave and 
a decrease in the S-wave amplitude in leads with terminal S wave 
on the surface ECG. Wong CK. et al, 2005. 
 
ISCHEMIA AT A DISTANCE  
    Patients with new Q waves and ST-segment elevation 
diagnostic for STEMI in one territory often have ST-segment 
depression in other territories. These additional ST-segment 
changes, which imply a poor prognosis, are caused either by 
ischemia in a territory other than the area of infarction, termed 
ischemia at a distance, or by reciprocal electrical phenomena. A 
good deal of attention has been directed to associated ST-
segment depression in the anterior leads, when it occurs in 
patients with acute inferior STEMI. Zimetbaum PJ. et al,2003 
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    However, despite the clinical importance of differentiation 
among causes of anterior ST-segment depression in such 
patients, including anterior ischemia, inferolateral wall 
infarction, and true reciprocal changes, such a differentiation 
cannot be made reliably by electrocardiographic or even vector-
cardiographic techniques. Although precordial ST-segment 
depression associates more commonly with extensive infarction 
of the lateral, or inferior septal segments, rather than anterior 
wall subendocardial ischemia, imaging techniques such as 
echocardiography are necessary to ascertain whether an 
anterior wall motion abnormality is present. De Luca G. et al, 
2005 
Role of Echocardiography  
  Echocardiography is an accurate, noninvasive test that is able to 
detect evidence of myocardial ischemia or necrosis. 
  Severe ischemia produces regional wall motion abnormalities 
(RWMAs) that can be visualized echocardiographically within 
seconds of coronary artery occlusion. These changes occur prior 
to the onset of electrocardiographic changes or the development 
of symptoms. The Regional wall motion abnormalities reflect a 
localized decrease in the amplitude and rate of myocardial 
excursion, as well as a blunted degree of myocardial thickening 
and local remodeling. Lang RM. et al, 2005 
    
   Assessment of segmental function and overall LV performance 
provides prognostic information and is essential when MI is 
extensive, as judged by use of enzymatic criteria, or when MI is 
complicated by shock or profound HF. In part, this assessment is 
done to identify potentially surgically correctable complications 
and to detect true ventricular aneurysms, false ventricular 
aneurysms, or thrombi. Møller JE. et al, 2008 
 
   Imaging is also useful in detecting pericardial effusion, 
concomitant valvular or congenital heart disease, and marked 
depression of ventricular function that may interdict treatment 
in the acute phase with beta-adrenergic blockers. 
Echocardiography is also helpful in delineating recovery of 
stunned or hibernating myocardium. Hillis GS. et al, 2006 
29 
 
 
   Doppler echocardiography is particularly useful in estimating 
the severity of mitral or tricuspid regurgitation; in detecting 
ventricular septal defects secondary to rupture; in assessing 
diastolic function; in monitoring cardiac output, as calculated 
from flow velocity and aortic outflow tract area estimates; and in 
estimating pulmonary artery systolic pressure. Perez de Isla et 
al,2006 
 
   Normal walls show a progressive increase in contractility 
(motion and thickening). Dead segments have poor motion and 
no thickening, and contractility fails to increase with high 
stimulation. Viable but jeopardized myocardium (ischemic 
myocardium) shows a biphasic response, wherein the 
contractility increases at lower doses of dobutamine and 
declines with perceptible wall-motion abnormalities at high 
doses of dobutamine. This kind of response is characteristic of 
ischemic myocardium and is most often the result of coronary 
stenosis. Davi G. et al, 2007 
Percutaneous Coronary Interventions for Myocardial 
Revascularization 
   In 1929, a young surgical resident from Germany was tooling 
around in an attempt to find a safe and effective way to inject 
drugs for cardiac resuscitation.  He anesthetized his left elbow, 
inserted a catheter into his antecubital vein, and confirmed the 
position of the catheter tip in the right atrium by use of 
radiography, thus performing the first documented human 
cardiac catheterization. Mueller RL et al, 1995  
   Forssmann further elaborated on his experiments to include 
intracardiac injection of contrast material through a catheter 
placed in the right atrium.  By 1958, Mason Sones had performed 
selective coronary arteriography in a series of more than 1,000 
patients. Dotter CT. et al, 1964; Forssmann W. et al, 1974 
   Melvin Judkins, a radiologist who had studied coronary 
angiography with Sones, introduced a series of specialized 
catheters and created his own system of coronary imaging in 
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1967 and perfected the transfemoral approach. Mueller RL. et 
al, 1995     
   Meanwhile in 1974 Andreas Gruentzig in Zurich substituted a 
balloon-tipped catheter for the rigid dilator and inaugurated the 
first peripheral balloon angioplasty in a human. Gruentzig A. et 
al, 1979 
   After perfecting coronary angioplasty in animals, Gruentzig 
then went on to perform intraoperative balloon angioplasty on 
the human heart for the first time.  Soon thereafter, Gruentzig 
and his colleagues described their technique of percutaneous 
transluminal coronary angioplasty (PTCA) as used in a series of 
50 patients. Hurst JW. et al, 1986 
  This Gruentzig technique was widely adopted and universally 
applied.  The era of percutaneous coronary intervention had 
arrived.  This technique quickly evolved into applications such as 
coronary atherectomy (1986) and coronary stenting (1987) and 
by 1997, angioplasty had become one of the most common 
medical interventions in the world. Trikalinos TA. et al, 2009 
   Currently, mortality rates for PCI from experienced operators 
in large series range from 0.5 to 1.7 percent. Overall, the 
improvements in devices, the use of stents, and aggressive 
antiplatelet therapy have significantly reduced the incidence of 
major peri-procedural complications of PCI in the last 20 to 25 
years.  This is evidenced by the fact that, the need for emergent 
coronary bypass surgery (CABG) decreased in two series from 
1.5% in 1992 to 0.14% in 2000,and from 2.9% in 1979 to 1994 
to 0.3% in 2000 to 2003. Keeley EC. et al, 2003 
    Primary percutaneous coronary intervention (PCI) to restore 
coronary blood flow is the current standard of care for ST-
elevation myocardial infarction (STEMI) PCI.  It carries a class IA 
recommendation from the American College of Cardiology 
(ACC)/American Heart Association (AHA) and 2005 Society for 
Cardiovascular Angiography and Interventions (SCAI) PCI 
guidelines.  In addition the Centers for Medicare & Medicaid 
Services (CMS)/The Joint Commission have established a door-
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to-balloon time of less than 90 minutes as one of the core clinical 
performance measures. Keeley EC. et al, 2003 
Drug-Eluting Stents 
    Drug-eluting stents are metal stents that have been coated 
with a polymer containing an anti-proliferative agent, gradually 
released over time after the stent is inserted. Theoretically, this 
should provide sustained inhibition of the neointimal 
proliferation (the process that is responsible for restenosis) 
occurring as a result of vascular injury.  The so-called first-
generation drug-eluting stents released sirolimus, rapamycin,  a  
natural cytostatic  macrocyclic  lactone  with  potent  
antiproliferative, anti-inflammatory, and immunosuppressive 
effects, acting by inhibiting the activation of the mammalian 
target of rapamycin (mTOR), ultimately causing arrest of the cell 
cycle, or paclitaxel, a chemotherapeutic agent that suppresses 
assembly and stabilization of microtubule. Morice M. et al, 2002 
   The Randomized Study utilizing the sirolimus-eluting Velocity 
Balloon Expandable Stent (RAVEL) demonstrated a stupendous 
0% rate of restenosis, as measured by angiography, and 
complete inhibition of neointimal hyperplasia in the group that 
received a sirolimus-eluting stent.  While 23% of the control 
group at one year required percutaneous revascularization of the 
treated lesion, the study group that received a sirolimus-eluting 
stent group required 0% revascularization.  This study led to the 
approval of the device in Europe. Moses JW. 2003 
   The SIRIUS trial confirmed the safety and efficacy of  the  
sirolimus-eluting stent in  single, previously  untreated coronary 
artery lesions, with a lower rate of in-stent restenosis than found 
with otherwise identical bare-metal stents (3.2% vs. 35.4%, 
P<0.001).  More studies confirmed that DES appeared to be 
superior to bare-metal stents (BMS) and to balloon angioplasty 
in reducing the magnitude of neointimal proliferation, the 
incidence of clinical restenosis, and the need for vascular re-
intervention. Stone GW. et al, 2007 
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2. Risk Stratification after STEMI 
 
   Initial risk stratification should be performed early with the use 
of information available at the time of presentation. However, 
risk assessment is a continuous process that requires 
recalibration on the basis of data obtained during the hospital 
stay. Such data include the success of reperfusion therapy, events 
that occur during the hospital course (such as hemorrhagic 
complications), and the findings from noninvasive and invasive 
testing, particularly as they relate to the assessment of LV 
systolic function. O’Gara et al, 2013 
 
    For example, in patients treated with fibrinolytic therapy, 
clinical and ECG indicators of failed reperfusion identify 
individuals who should undergo urgent coronary angiography 
with intent to perform PCI. In addition, the emergence of HF or 
significant LV systolic dysfunction is among the strongest 
predictors of higher-mortality risk after STEMI. Stable patients 
with a low risk of complications may be candidates for early 
discharge. Wijeysundera HC. 2007 
 
  Among patients with STEMI managed with fibrinolysis, it has 
been suggested that an uncomplicated course after 72 hours of 
hospitalization identifies a group with sufficiently low risk to 
enable discharge. Borgia F. et al, 2010 
 
Use of Noninvasive Testing for Ischemia before Discharge:  
Recommendations 
CLASS I 
1. Noninvasive testing for ischemia should be performed before 
discharge to assess the presence and extent of inducible ischemia 
in patients with STEMI who have not had coronary angiography 
and do not have high-risk clinical features for which coronary 
angiography would be warranted .(Level of Evidence: B) 
 
CLASS IIb 
1. Noninvasive testing for ischemia might be considered before 
discharge to evaluate the functional significance of a non-infarct 
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artery stenosis previously identified at angiography. (Level of 
Evidence: C) 
2. Noninvasive testing for ischemia might be considered before 
discharge to guide the post-discharge exercise prescription. 
Level of Evidence: C. O’Gara et al, 2013 
 
    Noninvasive testing for ischemia provides valuable 
information about the presence of residual ischemia in patients 
who have not undergone cardiac catheterization during initial 
management of STEMI and may be useful in assessing the 
functional significance of a non-infarct artery stenosis identified 
at angiography. In the latter instance, stress imaging to localize 
ischemia would be appropriate. Exercise testing early after 
STEMI may also be performed to 
 1) Assess functional capacity and the ability to perform tasks at 
home and at work, 
 2) Evaluate the efficacy of medical therapy, and 
 3) Assess the risk of a subsequent cardiac event. Symptom-
limited exercise testing is a key feature of the intake evaluation 
for enrollment in a program of cardiac rehabilitation2weeks 
after discharge. Thomas RJ. et al, 2010 
 
    Low-level exercise testing after MI appears to be safe if 
patients have undergone in-hospital cardiac rehabilitation, 
including low-level exercise; have had no symptoms of angina or 
HF; and have a stable baseline ECG 48 to 72 hours before the 
test. Thomas RJ. et al, 2010 
 
   Two different protocols have been used for early post-MI 
exercise testing: the traditional submaximal exercise test (done 
at 3 to 5 days in patients without complications) or a symptom-
limited exercise test (done at 5 days or later) without stopping at 
a pre-specified target heart rate or metabolic equivalent level. 
RCTs of early exercise testing after PCI have excluded patients 
with recent MI. Jain A. et al, 1993 
 
   Limited data exist on the safety of early symptom-limited 
exercise testing after MI; therefore, clinical judgment must be 
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used. Pharmacological stress myocardial perfusion imaging has 
been shown to have predictive value for post-infarction cardiac 
events and is useful and safe in patients who are unable to 
exercise. Jain A. et al, 1993 
 
  The optimum timing for provocative testing for ischemia after 
STEMI remains unresolved. It is argued that a pre-discharge 
exercise test may provide psychological benefit to the patient 
and will permit detection of profound ischemia or other 
indicators of high risk that could be associated with post-
discharge cardiac events that might occur before a symptom-
limited stress test scheduled weeks later. A pre-discharge study 
also provides parameters for exercise prescription in the first 
few days after return home, before enrollment in cardiac 
rehabilitation. Roffi M. et al, 2003 
 
   On the other hand, deferring exercise testing until 
approximately 3 weeks after STEMI in clinically low-risk patients 
appears safe and reasonable and enables more optimal 
assessment of functional capacity. It is the consensus of the 
writing committee that patients without complications who have 
not undergone coronary angiography and who might be 
potential candidates for revascularization should undergo 
provocative testing before hospital discharge. In patients with 
non-infarct artery disease who have undergone successful PCI of 
the infarct artery and have an uncomplicated course, it is 
reasonable to proceed with discharge and plans for close clinical 
follow-up with stress imaging within 3 to 6 weeks. Gibbons RJ. 
et al, 2006 
 
   Viable myocardium refers to reversible dysfunctional 
myocardium resulting from CAD. Reversible myocardial 
dysfunction in the setting of chronic CAD has been referred to as 
“hibernating myocardium.” Earlier descriptions of this entity 
emphasized the presence of a match between the decrease in 
myocardial perfusion and the presence of regional dysfunction. 
However, more recent studies have shown that contractility may 
35 
 
be reduced despite the presence of normal or only moderately 
reduced myocardial perfusion at rest. Meluzin J. et al, 1998 
 
    Most stress echocardiography protocols are centered on the 
detection of contractile reserve and have used inotropic 
stimulation with dobutamine. Naqvi T. et al, 1999 
 
   However, other modalities of stress echocardiography have 
been applied, including exercise, post-premature ventricular 
contraction stimulation, enoximone, and low-dose dipyridamole. 
Eichhorn E. et al, 2003 
 
   In comparison with the assessment of viability using nuclear 
perfusion tracers or contract echocardiography, a lower extent of 
interstitial fibrosis and greater percentage of viable myocytes are 
needed for the detection of contractile reserve by dobutamine 
echocardiography. Nagueh et al, 1999 
 
    This probably accounts for the higher sensitivity but lower 
specificity of myocardial perfusion imaging compared with 
dobutamine echocardiography in the detection of viable 
myocardium. Both low- and high-dose protocols have been 
shown to be useful for detection of viability. Earlier studies 
examined low-dose dobutamine, whereas other investigators 
emphasized the importance of reaching at least 85% of target 
heart rate in an attempt to uncover the presence of ischemia. 
Nagueh et al, 1999 
 
    Wall thickness should be assessed on the resting 
echocardiographic images. Segments that are thinned and bright 
(likely a result of advanced fibrosis) rarely recover. It is also 
useful to examine the mitral inflow pattern, particularly in 
patients who have received adequate medical therapy at the time 
of imaging. A pattern of restrictive LV filling is associated with 
few viable segments and a low likelihood of functional recovery 
after revascularization. Eichhorn E. et al, 2003 
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   Baseline imaging should include assessment for the presence of 
significant valvular disease that may alter surgical plans. After 
adequate baseline data have been obtained, dobutamine infusion 
is begun. An initial infusion of dobutamine at 2.5 µg/kg/ min, 
with gradual increase to 5, 7.5, 10, and 20µg/kg/min, is 
frequently used. Elsasser A. et al,1997 
 
    The advantage of the higher dose dobutamine is the potential 
to elicit ischemia. Dysfunctional myocardium responds to 
dobutamine in one of 4 ways that are most likely to be 
appreciated when the response to both high and low doses of 
dobutamine are considered. These responses include biphasic 
response (augmentation at a low dose followed by deterioration 
at a higher dose), sustained improvement (improvement in 
function at a low dose without deterioration at higher doses), 
worsening of function, and no change in function. Bito V. et al 
,2005 
 
   The sensitivity of dobutamine echocardiography in predicting 
functional recovery (which varies depending on the protocol 
used) ranges from 71% to 97%, with a specificity ranging from 
63% to 95%. Bito V. et al, 2005 
 
  Patients with a large area of viable myocardium (> 25% of LV) 
have a high likelihood of improvement in EF and a better 
outcome after revascularization compared with patients with 
less or no contractile reserve. Bito V. et al, 2005 
 
    Although presence of viability has been defined in various 
ways, it is recommended that improvement by at least one grade 
in two or more segments be demonstrated. A substantial amount 
of viable myocardium detected by low-dose dobutamine 
echocardiography has been shown to prevent ongoing 
remodeling after revascularization and to be associated with 
persistent improvement of heart failure symptoms and a lower 
incidence of cardiac events. Iyer V. et al, 2005 
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Cardiac MRI in post-STEMI assessment  
 
    Myocardial infarction (MI) can be detected with high 
resolution using a protocol known as late gadolinium 
enhancement CMR. Gadolinium is given intravenously and CMR 
is performed after a delay, using an inversion recovery sequence. 
Little gadolinium enters areas of normal myocardium, because 
there is uniform tightly packed muscle, and gadolinium is an 
extracellular contrast agent. However, the extracellular 
compartment is expanded in areas of MI because of cellular 
rupture, and therefore differential distribution occurs. Elliot et 
al, 2005 
 
   The kinetics of entry of gadolinium into the MI territory is 
delayed and the optimal time for imaging of the distribution of 
gadolinium is after 10 to 15 minutes. By nulling (forcing to near-
zero) the normal myocardial signal with adjustment of the 
inversion time, the area of infarction can be demonstrated with 
extremely high contrast relative to the black normal 
myocardium. A simple mnemonic is that “bright is abnormal.” 
Wu E. et al, 2001 
 
    The transmural distribution of MI can be visualized in vivo for 
the first time using this technique because of its high resolution. 
Animal models have validated this  In humans, late gadolinium 
enhancement CMR detects Q wave and non-Q-wave MI 
accurately and with such high sensitivity that small MIs can be 
demonstrated that are usually not apparent using gated 
perfusion single-photon emission computed tomography 
(SPECT; also, microinfarcts can be shown after percutaneous 
coronary intervention. Wagner A. et al, 2003 
 
    In the acute setting, the extent of late gadolinium enhancement 
is related to the magnitude of cardiac enzyme release and the 
functional outcome after recovery. Late gadolinium 
enhancement CMR reveals a permanent record of MI (both acute 
and chronic) and is proving very useful clinically for the 
diagnosis of MI in cases of doubt, or when other techniques are 
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inconclusive. The technique has clarified the pathological 
significance of Q waves after MI. It has good inter-study 
reproducibility, suggesting a useful role in studies of therapies 
for limiting MI in the acute setting. In the setting of acute MI, data 
have shown that the area at risk from coronary occlusion can be 
determined from T2-weighted imaging because the severely 
ischemic but non-infarcted myocardium becomes edematous; 
this significantly lengthens T2, which increases the signal. 
Selvanayagam JB. et al, 2005 
 
   The increase in T2 signal persists for many days, allowing 
edema to be imaged well after the acute event. The area at risk 
(T2 scan) is larger than the final infarction (late gadolinium 
enhancement scan) when myocardial salvage has occurred with 
physical or pharmacological intervention. This makes the 
combination of these two scans very attractive for studies of 
techniques to improve salvage and thence prognosis. Late 
gadolinium enhancement has been shown to be a major 
predictor of cardiac events in patients without a history of 
infarction, but in whom infarction is nonetheless present. Moon 
JC. et al, 2002 
 
   Further work has shown that CMR can differentiate between 
the densely bright infarct core and the adjacent peri-infarct zone, 
which appears with lower signal intensity because of the 
admixture of infarct and viable tissue. The greater the extent of 
the peri-infarct zone, the greater the likelihood of future cardiac 
death and events. Mahrholdt H. et al, 2002 
 
 
 
 
 
 
 
 
 
Figure 7: MRI findings in subendocardial infarction. Aletras AH. et al, 2006 
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3. Assessment of myocardial viability 
 
    The first descriptions of what would today be recognized as 
«viable myocardium» appeared in the 1970s, when it was 
observed that ventricular dysfunction reverted after 
revascularization in some patients with antecedents of acute 
myocardial infarction (AMI). The concept of viability is the 
opposite of that of necrosis, which implies an irreversible 
alteration in contractility. In patients with severe left ventricular 
dysfunction of ischemic origin, revascularization leads to 
improvements in ventricular function, survival and 
prognosis. Such improvements may be due to the presence of 
myocardial viability. Chatterjee K. et al, 1973. 
    From the clinical perspective, viable myocardium can be 
defined as myocardium in which contractile function is expected 
to improve, or in which remodelling can be avoided, once blood 
flow has been restored. 
   Simple diagnostic methods such as the electrocardiogram, 
resting echocardiography, and ventriculography are available to 
detect myocardial necrosis. Assessing myocardial viability poses 
two difficulties. In the first place, viability is not a dichotomous 
concept, as there are degrees of viability ranging from complete 
absence to total normality. In the second place, the lack of a 
standard reference model means that precise assessment of 
myocardial viability is not possible at present, so that results 
obtained with current assessment methods may be open to 
discussion. Schulz R. et al, 2000 
MECHANISMS OF VIABLE DYSFUNCTIONING MYOCARDIUM 
    In myocardium which suffers acute, subacute or persistent 
perfusion defects, nonfatal ischemia can occur, and in such cases 
viability is maintained but resting contractile function is altered. 
Responses to such nonfatal ischemia include stunning and 
hibernation. In both of these states, cell dysfunction may be 
reversed once coronary flow is restored. The terms myocardial 
hibernation and stunning are currently accepted within the 
cardiology community, although their clinical application has 
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been limited because they are difficult to determine precisely. 
The myocardium is said to be stunned when transitory post-
ischemic contractile dysfunction is present after coronary flow 
has been restored. After revascularization, contractile 
dysfunction persists temporarily and is followed by late 
recovery.  Hibernating myocardium is believed to be the 
consequence of discordance between flow and function, in which 
contractile function is altered as a response to a reduction in 
blood flow. Redwood SR. et al, 1998 
    Various mechanisms may be responsible for flow defects, 
including persistent perfusion defects at rest, reductions in the 
coronary flow reserve, or repeated episodes of ischemia and 
accumulated stunning. Recovery of contractile function once 
coronary flow is restored is, however, independent of the 
mechanism that produces hibernation. As with viability, 
hibernation should not be considered a dichotomous concept, 
but can be conceived of as a reaction involving progressive tissue 
dedifferentiation, which can eventually result in apoptosis. The 
more severe and longer-lasting the ischemic injury, the greater 
the degree of myocardial degeneration. In general, the study of 
viability in pre-revascularization patients means studying 
hibernating myocardium. Redwood SR. et al, 1998 
    In viable myocardium, cell membrane integrity is typically 
retained, and there is some mitochondrial activity, together with 
an active glucose metabolism, existence of coronary flow, and the 
presence of contractile reserve. AMI produces irreversible 
myocardial damage, and the extent of this damage will determine 
functional recovery in the ventricular wall and the possibility of 
avoiding remodelling. Irreversible damage to the myocytes alters 
their metabolism and contractile function, and leads to their 
replacement with scar tissue and subsequent loss of contractile 
muscle mass. St. Louis J.D. et al, 2000 
IMPORTANCE OF DEFINING VIABILITY IN PRE-
REVASCULARIZATION PATIENTS 
    Assessing myocardial viability is of particular interest in 
patients in whom regional contractility is severely affected, as it 
helps to determine which segments of ventricular wall are viable 
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and may be suitable for revascularization. In over 50% of 
patients with antecedents of electrocardiographically 
documented infarct, viable myocardial regions and necrotic 
tissue exist side by side. However, the prior existence of necrosis 
does not necessary affect segment contractility. In a prospective 
study, regional contractile dysfunction was observed in 33% of 
patients who had ischemic cardiomyopathy but no 
electrocardiographic evidence of infarct, and functional recovery 
after revascularization was found to occur in 85% of the 
dysfunctioning segments. From the point of view of prognosis, 
the most important factor is the existence of severe global 
ventricular dysfunction. In patients with coronary disease, 
depressed ejection fraction, and cardiac insufficiency - with or 
without angina - assessing myocardial viability can be helpful in 
deciding whether there is an indication for revascularization. 
The prevalence of viable myocardium in patients with ischemic 
cardiomyopathy and global contractile dysfunction of the left 
ventricle is considerable, and ranges between 29% and 55% 
depending on the series. Taneja A. K. et al, 2010 
   Determining viability in patients with left ventricular 
dysfunction is also important from the prognostic point of view. 
When treated conservatively, patients with depressed 
ventricular function and signs of viability have higher mortality 
than patients without viability. Likewise, revascularization has 
been shown to improve long-term prognosis in the former group, 
which may be explained by an improvement in overall 
ventricular function in patients with viability. In patients with 
ischemic cardiomyopathy, functional recovery after 
revascularization is a sufficient but not necessary condition for 
improved prognosis, as cases in which revascularization does 
not increase left ventricular ejection fraction may also present a 
favourable course. Where viability is present, revascularization 
improves both prognosis and functional class in these patients. J. 
E. Møller, K et al, 2003. 
   Determining the extent of viable myocardium to be 
revascularized allows thresholds to be defined above which 
improvements in global ventricular functioning and patients' 
functional capacity can be expected. Studies with cardiac 
magnetic resonance imaging (CMRI) in patients with AMI have 
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shown that the recovery of contractile function in ventricular 
segments depends on the extent of viable myocardium in the 
thickness of the ventricular wall.  L. E. J. Thomson et al, 2004.  
Diagnostic testing of myocardial viability 
   Living myocardium is characterized by preserved ventricular 
wall thickness, the presence of contractile reserve, cell 
membrane integrity, active myocyte metabolism, and the 
existence of blood perfusion. Diagnostic techniques for studying 
myocardial viability are based on detecting one or more of these 
markers. The preservation of ventricular wall thickness and 
contractile reserve are usually investigated using 
echocardiography or stress CMRI. Myocyte membrane integrity 
and blood perfusion can be evaluated using gammagraphy with 
thallium or technetium contrasts, positron emission tomography 
(PET), and contrast CRMI. PET and CRMI spectroscopy can detect 
metabolic defects in nonviable myocardium. K. Shan G. et al, 
2004 
   The importance of these markers is relative, as myocardial 
necrosis may not be transmural and may coincide with viable 
myocardium in the same segment of the ventricular wall. The 
ideal diagnostic technique would be one which provided 
sufficient spatial resolution to determine the quantity of viable 
myocardium in the same ventricular segment. Of all the 
techniques mentioned, CMRI provides the best spatial resolution. 
L. E. J. Thomson, et al 2004 
   The image-based diagnostic techniques used in cardiology aim 
to identify the presence and extent of viable myocardium using 
noninvasive methods. Such techniques include dobutamine 
echocardiography, thallium and technetium scintigraphy, PET 
and more recently CMRI. The choice of technique to be used will 
be based on availability and experience. Because of its high 
sensitivity, PET has generally been considered the gold standard 
for determining viability; however, its limitations and cost have 
restricted its use. P. G. Camici et al, 2008 
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Markers of myocardial viability 
Ventricular wall thickness 
   Studies have indicated that nonviable myocardium is 
frequently associated with a significant thinning of the 
ventricular wall. When myocardial necrosis leads to considerable 
myocyte loss, a process of fibrosis begins which results in loss of 
myocardial wall thickness. The small number of living myocytes 
remaining is insufficient to recover contractility once 
reperfusion is achieved after revascularization. La Canna GL. et 
al, 2000 
Echocardiography 
This is a quick and accessible method for estimating reductions 
in thickness in the akinetic or dyskinetic wall. Increased 
refraction may also be a sign of fibrosis. When using 
echocardiography, a reduction in the diastolic thickness at rest to 
below 5 mm, and the presence of akinesia or dyskinesia, indicate 
nonviable myocardium. Such a finding has high negative 
predictive accuracy for viability, and means that more complex 
diagnostic procedures can be avoided. Conversely, a diastolic 
thickness of over 5 mm provides a sensitive (100%), but not very 
specific (28%) marker of viability. Although echocardiography is 
accessible and economic, its limited specificity and poor 
reproducibility mean that it is of little practical use. Where wall 
thickness is reduced, more specific markers need to be used. Cho 
S. et al, 2002. 
Contractile reserve 
   One objective of revascularizing viable myocardium is to 
recover contractile function. Echocardiography and stress 
CMRI can be used to determine the level of contractile reserve 
in viable myocardium, and to predict its functional recovery. 
However, even where contractile reserve is not shown to exist, 
viability may still be present. In some patients with a small  
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proportion of viable myocardium, revascularization may not 
lead to recovery of contractility in the myocardial wall, but it 
can avoid ventricular remodelling. Klein C. et al, 2002. 
Stress echocardiography 
   Contractile reserve is demonstrated using echocardiography 
in combination with stress-inducing protocols based on 
progressive exercise or continuous perfusion of drugs such as 
dipyridamole, nitroglycerin, postextrasystolic potentiators, 
enoximone and the catecholamines (including isoprenaline, 
adrenaline, dopamine and dobutamine). Enoximone is a 
positive inotropic drug which inhibits cyclic adenosine 
monophosphate (cAMP) phosophodiesterase, and in 
preliminary studies in small numbers of patients, it has shown 
the greatest diagnostic precision of the drugs listed, with a 
sensitivity and specificity of 88% and 89%, respectively. 
However, dobutamine stress echocardiography is the most 
widely used and best-documented stress echocardiographic 
technique for detecting myocardial viability. Dobutamine 
preferentially stimulates beta-1-adrenergic receptors. At low 
doses (5 and 10 µg/kg/min) it produces more of an inotropic 
than a chronotropic effect, leading to improved contractility in 
the hibernating myocardium. Cho S. et al, 2002 
  At higher doses, both the inotropic effect and heart rate are 
increased, thereby increasing oxygen consumption and 
ischemia in territories irrigated by stenosed coronary 
arteries. When significant coronary stenosis exists, once the 
existence of contractile reserve has been demonstrated at low 
doses of dobutamine, contractility worsens at ischemic doses. 
The result is a two-phase response consisting of initial 
improvement, indicating viability, and later worsening due to 
the flow defects which produce the induced ischemia. Such a 
two-stage response is characteristic of hibernating 
myocardium, and predicts recovery of ventricular function 
after revascularization. Cho S. et al, 2002 
   In comparison with single photon emission computed 
tomography (SPECT) and PET, dobutamine stress 
echocardiography shows greater specificity in the diagnosis of 
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myocardial viability (81% against 73%) and lower sensitivity 
(84% against 90%). Sawada S. et al, 2000 
Cardiac magnetic resonance imaging 
   Infarcted viable myocardium may have lost contractile 
function because of perfusion defects, which produce 
significant stenosis in the coronary artery involved. In this case, 
when stress is induced by progressive doses of dobutamine or 
exercise, the result is the two-stage response described 
previously. Long experience with stress echocardiography 
means this procedure has been widely studied. However, some 
patients may not have an adequate ultrasonic window, and in 
these cases cardiac magnetic resonance imaging (CMRI) 
provides a useful alternative which has also proved reliable in 
identifying viable myocardium. Gerber BL. et al, 2002 
   With CMRI the window for studying the heart is not limited, 
and equipment incorporating the latest technical advances will 
ensure a quick and accurate exploration. Significant systolic 
thickening of any segment of the akinetic or dyskinetic 
ventricular wall observed using stress CMRI is indicative of 
viability. This marker is more accurate if it is combined with 
the wall thickness analysis referred to earlier. Although the 
monitoring of patients undergoing CMRI is complicated, there 
should be no additional risk if qualified personnel are available 
and adequate procedures are used. Gerber BL. et al, 2002 
Gated SPECT 
   Obtaining isotopic images of myocardial perfusion, 
synchronized with electrocardiogram and gated SPECT, 
permits the simultaneous evaluation of perfusion and 
contractility at a global and segmental level. When this 
technique was used to assess viability by studying contractile 
reserve during dobutamine perfusion at 10 µg/kg/min, it 
provided a sensitivity of 96% and a specificity of 78% (the 
capacity of dobutamine gated SPECT at rest to predict 
contractile recovery after revascularization in dyssynergic 
myocardial regions. Dilsizian Vet. al,2005 
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  Positron Emission Tomography  
 
   Cardiac positron emission tomography (cardiac PET) involves 
the administration of a tracer, Rubium-82, Ammonium-13, 
Water-15, and Fluorine-18 deoxyglucose (18-FDP). Of these 
various positron-emitting radiotracers, which are peripherally 
introduced, a glucose analogue; Fluorine-18 deoxyglucose (18-
FDP), is the most validated radiotracer for cardiac PET 
metabolism. Glucose 11-C, free fatty acid (FFA), and Oxygen are 
also metabolism tracers, however glucose is the preferred 
metabolite for assessment of ischemic or hypoxic myocardium. 
The most commonly used criterion to identify viable 
myocardium is the uptake and metabolism of 18-FDP, which is 
dependent on viable myocytes, with viable glucose 
transporters. Viable myocardium displays normal perfusion 
and normal 18F-FDG uptake, hibernating myocardium displays 
reduced perfusion and preserved 18F-FDG uptake but, scarred 
tissue will display no perfusion and absent 18F-FDG uptake. 
Lautamäki R. et al,2009 
 
Strain rate imaging  
 
    An increase in strain rate, defined as the tissue velocity 
gradient between two points within a myocardial territory, by 
more than −0.23 (1/s) with low-dose dobutamine (10 μg/kg 
body weight) has a sensitivity of 83% and a specificity of 84% for 
predicting viability compared to FDG PET . Bansal M. et al,  
2010 
 
  It was found that global LV strain, the change in the length of a 
region of interest from end-diastole to end-systole, assessed with 
novel automated function imaging (AFI) using speckle tracking 
from 2D gray-scale images, predicted patients who had an 
improvement in LV ejection fraction following myocardial 
infarction. Baseline AFI of −13.7% had a sensitivity of 86% and a 
specificity of 74% to predict LV functional recovery at 1 year. 
Also, longitudinal strain and strain rate imaging at rest and low-
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dose dobutamine were shown to be predictors of functional 
recovery after revascularization. Bansal M. et al,  2010.   
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4. Strain rate imaging 
  
    Cardiac motion and deformation occur in three dimensions.  
The heart rotates and repositions (circumferential), shortens and 
dilates in longitudinal direction and thickens and relaxes in 
radial orientation during cardiac cycle. Perk G. et al, 2007 
 
 
Figure 8. 3D-illustration of a hypothetical myocardial segment.  Myocardial 
motion and deformation consist of three major components:  longitudinal, 
radial  and  circumferential.  The total deformation of a myocardial segment is 
very complex and includes shortening, thickening and rotatory movement. A. 
Stoylen et al, 2015 
 
Definitions related to Motion; Velocity and Displacement  
 
    The amount of motion normalized to time is defined to be the 
velocity of the object. It is  thus  the  displacement  of  the  object  
divided  by  the  time  required  to  make  the  displacement. [The 
object in Tissue Tracking Echocardiography (TTE) is mainly a 
single point or a Region of Interest (ROI).] Hence, its unit is cm/s. 
Velocity is used to describe how fast the myocardium moves in a 
particular direction.  During systole myocardium travels towards 
apex and velocities are positive in nature. During diastole heart 
muscle moves  to  its  initial  position  and  diastolic  velocities  
are  negative. Displacement is the measure  defining  how  far  a  
myocardial  segment  moves  from  an  initial  point.  In fetal 
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echocardiography its unit is mm and indicated positively. 
Dandel M. et al, 2009 
 
Definitions related to Deformation  
 
Strain  
   Strain (S) is defined as the deformation of an object, normalized 
to its original shape. In a one-dimensional concept the only 
possible deformation is lengthening or shortening. This is 
illustrated in Figure 9. Blessberger H.  et al, 2010 
 
 
 
 
 
 
 
Figure 9: Strain pattern of a 
region of the heart in the 
longitudinal direction. L0; 
original length at end 
diastole, L; length after 
deformation. At the right 
lower corner a Strain curve 
example.  Blessberger H et 
al, 2010 
 
  
 
 
 
 
 
 
  By convention, the expression is defined in such a way that  
lengthening  is  represented  as  a  positive  value  for  S,  while  
shortening  is represented  by  a  negative  value  (Figure 10 ).  
When  the  length  of  an  object  is  known before  (at  the  state  
of  L0)  and  at  the  end  of  deformation  (L1  at  a  random  time  
frame) Lagrangian  strain  can  be  defined. 
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Figure 10. Acquisition of Lagrangian strain through shortening and 
lengthening of cardiac tissue. A. Stoylen et al, 2015 
 
    However the deformation of the object can also be expressed 
relative to the length at a previous time instance (natural strain). 
According to this approach it is possible to evaluate the amount 
of deformation occurring during an infinitesimal time interval. 
For cardiac applications, it has been suggested that it may be 
more  appropriate  to  measure  natural  strain,  since  the  values  
measured  are  less dependent  on  the  definition  of  the  initial  
length  L0  rather  than  on  a  previous  time instance. 
Blessberger H. et al, 2010   
 
   Speckle-tracking echocardiography has recently emerged as a 
quantitative ultrasound technique for accurately evaluating 
myocardial function by analyzing the motion of speckles 
identified on routine 2-dimensional sonograms. It provides non-
Doppler, angle-independent, and objective quantification of 
myocardial deformation and left ventricular systolic and 
diastolic dynamics. By tracking the displacement of the speck-les 
during the cardiac cycle, strain and the strain rate can be rapidly 
measured offline after adequate image acquisition. Geyer H. et 
al, 2010 
 
    The term speckle tracking implies that this technique is 
principally based on the analysis of speckles during the cardiac 
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cycle. Single speckles are merged in functional units (kernels) 
that are in turn univocally identifiable given the peculiar 
disposition of the speckles. As a result, each kernel constitutes a 
sort of ultrasound fingerprint that can be tracked by software 
during the entire cardiac cycle. Geyer H. et al, 2010 
 
   According to the indications derived from the literature and to 
reduce random noise, each sample for a speckle-tracking 
echocardiographic analysis must be obtained by averaging at 
least 3 consecutive heart cycles, setting the frame rate of the 
routine 2-dimensional image acquisition between 60 and 110 
frames per second. Buchalter MB. et al, 1990 
 
 
 
Figure11. Speckle-tracking echocardiographic analysis of myocardial 
deformation showing measurements of longitudinal strain. Dandel M.  
et al, 2009 
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Term Definition 
Table2 .  Speckle-Tracking Echocardiographic Terminology  
 
How to Obtain Strain Parameters 
Image Acquisition 
    Images for speckle-tracking echocardiographic analysis, 
currently performed offline, are obtained and recorded by using 
conventional 2-dimensional gray scale echocardiography during 
breath holding with stable electrocardiographic tracing. Care 
must be taken to obtain true apical and short-axis images using 
standard anatomic landmarks in each view and to avoid 
foreshortening of the analyzed myocardial structure, thus 
allowing a more reliable delineation of the endocardial border. 
The optimal frame rate for the 2-dimensional image acquisition 
is set between 60 and 110 frames per second.  Shaw SM. et al, 
2008 
 
     These settings are recommended to combine high temporal 
resolution with acceptable spatial definition and to enhance the 
feasibility of the frame-to-frame tracking technique. It is 
recommended to begin with speckle-tracking echocardiographic 
analysis of an apical long-axis chamber view to select the frame 
corresponding to the aortic valve closure, which is a useful 
reference for the subsequent analysis. Apical 4- and 2-chamber 
view acquisitions are necessary for longitudinal strain and peak 
atrial longitudinal strain analysis. Altiok E. et al, 2012 
 
Strain    Myocardial deformation 
Strain rate     Myocardial deformation rate  
                                     velocity 
Longitudinal strain  Base-to-apex–directed deformation 
Radial strain              Myocardial deformation directed    
                                      radially  toward the center of the   
                                       left  ventricular cavity 
Circumferential strain     Left ventricular myocardial   
                                       shortening observed in a short-axis  
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   Short-axis recordings, useful for radial strain, circumferential 
strain, and rotation analysis, are obtained from a standard 
parasternal probe position for the basal plane and from a more 
distal anterior or anterolateral position for the apical plane. To 
standardize acquisitions, the basal plane is identified as the 
plane including the tips of the mitral leaflets, whereas the apical 
plane is identified dis-tally to the papillary muscles as the plane 
just proximal to the level at which LV cavity end-systolic 
obliteration occurs. Particular attention should be paid to 
making the LV cross section as circular as possible. Altiok E. et 
al, 2012 
 
Offline Analysis  
 
Recordings are processed using specific acoustic-tracking 
software usually available on dedicated workstations, allowing 
for an offline semi-automated analysis of speckle-based strain. 
The endocardial surface of the myocardial segment analyzed is 
manually traced in apical and/or short axis views by a point-and-
click approach. An epicardial surface tracing is then 
automatically generated by the system, thus creating a region of 
interest. After manual adjustment of the region of interest width 
and shape, the software automatically divides the region of 
interest into 6 segments, and the resulting tracking quality for 
each segment is automatically scored as either acceptable or 
unacceptable, with the possibility of further manual correction. 
Segments for which no adequate image quality can be obtained 
are rejected by the software and excluded from the analysis. 
Belghiti H. et al, 2008 
 
    Last, once the region of interest is optimized, the software 
generates strain curves for each selected myocardial segment. 
From these curves, the operator can obtain regional and global 
(by averaging values observed in all segments) peak and time-to-
peak values. If the longitudinal strain analysis is performed in all 
3 apical views, the software automatically generates a 
topographic representation of all 17 analyzed segments (bull’s-
eye acquisition). Belghiti H. et al, 2008 
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Clinical Applications 
 
   In general, speckle-tracking echocardiography may allow an 
unprecedented in-depth evaluation of myocardial systolic and 
diastolic dynamics across a broad range of physiologic and 
pathologic conditions beyond traditional echocardiographic 
techniques. For example, not only has a good correlation 
between longitudinal strain and the left ventricular ejection 
fraction (LVEF) been shown in several studies, but in addition, 
longitudinal strain provides a quantitative myocardial 
deformation analysis of each LV segment, also allowing for early 
systolic dysfunction detection in patients with a preserved LVEF. 
Takigiku K. et al, 2012 
 
- Hypertension 
Arterial hypertension is an ideal model for assessing the changes 
in different varieties of deformation occurring hand in hand with 
the development of LV concentric geometry  (concentric 
remodeling and concentric LV hypertrophy). This is a crucial 
issue because experiences using standard echocardiography 
have shown that impairment of midwall fractional shortening of 
the circumferential fibers precedes the reduction of the LVEF. 
Anwar A. et al, 2013 
 
   Speckle-tracking echocardiography has furthered the 
understanding that the interaction of the different deformations 
is much more complex under these circumstances. In particular, 
it seems that longitudinal and radial strain are impaired when 
circumferential strain is still normal and LV torsion, also  
maintained in the normal range, acts as mechanistic 
compensation to preserve a normal ejection fraction (EF). 
Anwar A. et al, 2013 
- Diabetes 
     In asymptomatic diabetic patients with a preserved LVEF, it 
has been shown that speckle-tracking echocardiography has the 
potential for detecting subclinical LV systolic dysfunction, which 
is unmasked by the alteration of longitudinal strain. In this view, 
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speckle-tracking echocardiography might provide useful 
information about the development of subclinical myocardial 
dysfunction in the diabetic setting before the overt appearance of 
diabetic cardiomyopathy. This evidence confirms previous 
experiences using either color tissue velocity imaging or 
Doppler-derived strain rate imaging. Nakai H. et al, 2009 
- Coronary Artery Disease 
    It was reported that a lower longitudinal strain value in 
asymptomatic patients without wall motion abnormalities is a 
strong predictor of stable ischemic cardiomyopathy. Choi JO. et 
al, 2009 
 
   Studies in patients with acute myocardial infarction found that 
longitudinal strain is related to peak levels of cardiac troponin T 
and the LV infarct size. Moreover, when measured immediately 
after reperfusion therapy, longitudinal strain is an excellent 
predictor of LV remodeling and adverse events, such as 
congestive heart failure and death. Choi JO. et al, 2009 
 
   In addition, it has been shown that longitudinal strain 
correlates with the global and regional extent (transmurality) of 
scar tissue as evaluated by contrast-enhanced MRI.  
 
    A radial peak strain cutoff value of 17.2% predicts LV 
functional recovery after revascularization with accuracy similar 
to that of a cutoff value of 43% hyper-enhancement on MRI. A 
cutoff value of –4.5% for regional longitudinal strain 
discriminates between segments with a viable myocardium and 
those with transmural scar tissue on contrast-enhanced MRI, 
with sensitivity of 81.2% and specificity of 81.6%. Bansal M. et 
al, 2008 
 
   Recently, speckle-tracking echocardiography was used to 
validate an analysis of post-systolic motion, identified as LV 
regional myocardial motion after aortic valve closure, and 
showed that the post-systolic index represents an important 
quantitative marker for analysis of the ischemic myocardium. 
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However, data from studies on large populations are still lacking. 
Voigt JU. et al, 2004 
 
- Valvular Heart Disease 
   Speckle-tracking echocardiographic analysis in patients with 
valvular heart disease has been mainly performed for the 
evaluation of LV function with stress (exercise or pharmacologic) 
testing. In asymptomatic patients with degenerative mitral 
regurgitation undergoing valvular surgery, limited exercise-
induced longitudinal LV contractile recruitment, as assessed by 
speckle-tracking echocardiography with global longitudinal 
strain, predicts postoperative  LV dysfunction. Lancellotti P. et 
al,2008 
 
   In patients with aortic stenosis or aortic regurgitation 
immediately after aortic valve replacement, there is a substantial 
increase in radial and circumferential strain, suggestive of how 
these myocardial deformation parameters critically depend on 
LV load conditions. Becker M. et al,2007 
 
- Heart Failure 
    It has been shown that in hypertensive patients with heart 
failure and in patients with heart failure and a normal EF, LV 
longitudinal strain progressively deteriorates from New York 
Heart Association class I to class IV, with additional LV radial and 
circumferential systolic impairment occur-ring in New York 
Heart Association functional classes III and IV. Park SJ. et 
al,2008 
  As for LV rotation and torsion analysis, Park et al reported that 
systolic twisting, torsion, and diastolic untwisting are 
significantly increased in patients with mild diastolic 
dysfunction. In patients with advanced diastolic dysfunction and 
increased filling pressures, these parameters are normalized or 
reduced. Kosmala W. et al,2008 
 
- Mechanical Dyssynchrony 
     Cardiac resynchronization therapy is an effective treatment 
option for patients with New York Heart Association functional 
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class III and IV heart failure who have an LVEF of 35% or less 
and QRS prolongation and who remain symptomatic despite 
optimal medical therapy. However, about 30% of patients fail to 
show a substantial benefit with cardiac resynchronization  
therapy, and several efforts have been made in recent years to 
identify non-responders be-fore implantation. A variety of 
echocardiographic parameters potentially suitable for predicting 
the response to cardiac resynchronization therapy have been 
tested. Tanaka H. et al, 2009 
 
   In a recent multicenter trial, none of 12 conventional and tissue 
Doppler-based echocardiographic indices of dyssynchrony was 
shown to be a reliable predictor of the response to cardiac 
resynchronization therapy. Tops LG. et al, 2009 
 
  However, strain parameters recently have been shown to have 
good reproducibility and accuracy in discriminating healthy 
patients from cardiac resynchronization therapy volumetric 
responders. Nesser HG. et al, 2009 
 
- Cardiomyopathies 
   In patients with nonobstructive hypertrophic cardiomypathy 
and a preserved EF, speckle-tracking echocardiography has 
shown the capability to identify early major abnormalities of all 
strain components of myocardial deformation (longitudinal, 
circumferential, and radial strain). Another potential clinical 
application of speckle-tracking echocardiography is for 
differentiation of hypertrophic cardiomyopathy from athlete’s 
LV hypertrophy based on the lower longitudinal strain values in 
patients with hyper-trophic cardiomyopathy who have a normal 
LVEF. Stefani L. et al, 2009 
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Methods 
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    Forty nine patients were enrolled from Mai 2013 until 
December 2014 from the coronary care unit (CCU) at the 
hospital in Coburg. The Patients were diagnosed with ST 
elevation myocardial infarction patients based on their ECG, 
laboratory findings and symptoms at admission. A follow up 
study was undertook at 6 weeks after STEMI.  
 
A written consent was taken from all recruited patients after 
clarifying the details of Stress-Echo and MRI- procedures and the 
possible complications. All obtained clinical and personal data was 
objected to medical data protection.  
 
 
Inclusion criteria 
            Patients with acute ST elevation myocardial infarction 
documented by ECG, elevated cardiac enzymes, cardiac Troponin 
I and conventional echocardiography study. 
Exclusion criteria 
1- Patients with very poor acoustic window due to 
marked obesity or Chronic Obstructive Pulmonary 
Disease (COPD). 
2- Patients with arrhythmia either ventricular or 
supraventricular. 
3- Patients with absolute contraindications to stress 
test. 
4- Patients with congenital heart diseases 
5- Patients who are contraindicated to perform a 
cardiac MRI test (with pacemaker, cochlear implants and 
patients with diagnosed claustrophobia).  
6- Acute myocardial infarction <4 days 
7- Known relevant left main coronary artery stenosis 
or three vessel disease. 
8- Manifest congestive heart failure 
9- Hypertrophic obstructive cardiomyopathy 
    10-     Acute pericarditis, myocarditis and endocarditis 
          11-    Aortic dissection 
 
All patients were subjected to  
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1- Full medical history. The onset, duration and 
progression of symptoms were precisely obtained from 
all patients.  
2- Complete clinical examination, including heart and 
lung auscultation, checking of signs of manifested cardiac 
decompensation (peripheral edema, jugular venous 
distention or palpation of liver). 
3- Standard 12 leads resting ECG. 
4- Conventional resting transthoracic 
echocardiography study. 
5- Dobutamine stress echocardiography (low dose 
dobutamine at 4 days and full stress dobutamine testing 
at 6 weeks). 
6- Automated functional imaging (Speckle tracking) 
echocardiography study of left ventricle. 
7- Cardiac MRI as the gold standard method in 
detecting myocardial viability.  
 
Echocardiography 
   Examinations were performed with a   digital ultrasonic device 
system (Vivid 9 2013, GE Vingmed Ultrasound, Horten, Norway). 
The patients were examined 96 hours after revascularization 
using M4S probe in left lateral position. In harmonic mode 
2.0/4.3 MHz with maximal frame per second (FPS) count 
available at necessary sector width. Range of FPS was from 64 to 
112 with mean value 83. Lang RM. et al, 2015 
 
   Conventional echocardiography study was done including 2D 
based M-mode measures of cardiac chambers and Ejection 
Fraction (EF%), pulsed and continuous wave Doppler studies, 
Color Doppler study, calculation of ejection fraction by Simpson`s 
method and analysis of wall motion abnormalities. Regional wall 
motion abnormalities were analyzed using wall motion score. 
Lang RM. et al, 2015 
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Dobutamine stress Echocardiography 
 
  All patients underwent low dose dobutamine stress 
echocardiography 4 days post-STEMI as well as a full 
dobutamine stress testing follow up study at 6 weeks.  
-Patient was prepared for standard stress testing after obtaining 
a written consent. 
-Intravenous access was obtained. 
-Digital images were acquired at baseline (these loops are 
displayed and used as reference throughout the infusion). 
-Continuous electrocardiogram and blood pressure monitoring 
were established. 
-Dobutamine infusion  began at a dose of 10 µg/kg/min. 
-The infusion rate is increased every 3 minutes to doses of  20, 
30, and 40 µg/kg/min. 
-Peak images were acquired before termination of the infusion. 
-Post-stress images were recorded after return to baseline. 
-The patient was monitored until he or she returns to baseline 
status. 
 
    Whereas atropine was added in 0.5 mg fractional doses after 
the second stage of infusion up to the total dose of 2 mg. The 
infusion of dobutamine was stopped when age-adjusted HR limit 
was reached or when patients experiences criteria for 
terminating ( angina pectoris or dyspnea)For safety reasons, the 
presence of minimum two persons during each study was 
mandatory. Lancellotti P. et al, 2016 
 
   Then total wall motion score were divided by number of 
analyzed segments i.e. 17 segments in order to calculate the wall 
motion score index with normal wall motion score index is 1 and 
higher values represented progressive greater degrees of left 
ventricular dysfunction. Lancellotti P. et al, 2016 
 
Strain rate obtained by Speckle Tracking study 
 
    Left ventricle (LV) was recorded in 2D cine-mode in 3 views: - 
apical 4 chambers, apical 2 chambers and apical 3 chambers. 
Then LV was studied by offline analysis through the external 
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work station. Three points were selected in each view (2 points 
at the base and 1 point at the apex) then the program 
automatically tracked the endocardial border of LV in each view. 
Regional and global strain of LV were calculated automatically 
and expressed in Bull's eye form based on 17 myocardial 
segmentation system that showed average global strain and peak 
systolic strain of each myocardial segment giving it a specific 
color according to value of peak systolic strain. Color ranges 
between dark red for normal myocardial segments and dark blue 
for severely dyskinetic segments with hypokinetic and akinetic 
segments between those colors. The parameters were defined as 
the peak deformation in longitudinal direction achieved for 
assessed segment during systole, before the aortic valve closure. 
Correlations were calculated for global and regional longitudinal 
strain in all segments. Bansal M. et al, 2013 
 
Cardiac MRI 
 
    Magnetic resonance imaging was performed using a 1.5-T 
scanner (Magnetom Vision Plus, Siemens, Erlangen, Germany) 
and a phased array body coil. Breath-hold cine images with a 
time resolution of 35 ms were acquired. Approximately 10 to 20 
min after intravenous injection of 0.1 mmol/kg gadopentetate 
dimeglumine, late enhancement images were obtained from the 
long-axis views, followed by multiple short-axis slices covering 
the entire left ventricle. Zhang S. et al, 2014 
 
   A breath-hold segmented magnetization-prepared turbo 
gradient echo sequence was used. The basal and midventricular 
short axis slices were divided into6 segments, and the apical 
short axis slices were divided into 4 segments. In our study, 
findings in the apex were not used. In each of the LV segments, 
the area of the entire myocardium was manually drawn. Infarct 
was defined as areas with pixel intensities > 2 SD of the mean 
pixel intensity in normal myocardium in the same slice. In each 
segment, the infarct size was calculated as percentage of the total 
segment area. The total infarct size was reported as percent of 
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LV mass and in units of grams of the infarcted myocardium. 
Zhang S. et al, 2014 
 
Primary PCI 
 
   After laboratory and electrocardiographically confirmation 
together with the presented symptoms of STEMI, the patients 
were transferred urgently to the heart catheter laboratory. A 
primary PCI was conducted through one of the interventional 
cardiology consultant through arterial access (either radial or 
femoral artery). No parallel admission of thrombolytic therapy 
was conducted.       
Statistical analysis 
 
   Statistical analysis was performed using MedCalc V.12.1.4. 
(Frank Schoonjans Belgium). Continuous variables were 
expressed as means and standard deviations. Mean values were 
compared with t Student test for paired variables. Chi square test 
was used to test the dichotomous variables distribution. For 
comparison of parameters obtained by STE and AFI Pearson 
correlation coefficients were calculated and Bland–Altman 
analysis performed. For interobserver variability assessment we 
calculated coefficients of variance. Duration of STE and AFI 
calculations and interobserver agreement were assessed in the 
group of 12 randomly selected subjects. Receiver-operating 
characteristic (ROC) curves were constructed, and areas under 
curves were measured to determine cutoff values with maximum 
sensitivity and specificity. A p value < 0.05 was considered 
statistically significant. We performed a multivariate regression 
analysis to find the best method for estimating final infarct size 
using MRI as the reference method. 
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     We examined 49 patients in whom ST elevated myocardial 
infarction was diagnosed depending on the clinical presentation, 
ECG results and laboratory findings. The patients were subjected 
to primary PCI procedures in less than 6 hours of symptoms 
beginning.  They were examined with echocardiography at rest 
and at low dobutamine stress on 4 days and at rest and high 
dobutamine stress on 6 weeks to determine the global and 
regional strain rate values. All patients were evaluated through 
cardiac MRI as a gold standard method of determining 
myocardial viability at 4 days and 6 weeks as well.  
 
   Women accounted for 49% of our study cohort (No. 24) 
whereas Men were 51% of the patients (No. 25). Thirty-one 
patients were hypertensive while twenty-one were already 
diagnosed with diabetes before admission with STEMI. Twenty-
one of the studied group were smokers (57%) and twenty-four 
showed either elevated lipid profile or were taking lipid-
lowering drugs. Five patients had experienced a previous acute 
coronary syndrome in their medical history while eight of them 
had previous coronary interventions (PCI) with stent 
implantation (Table 3). 
 
The mean age in our study group was 64 years old + 9.7 and 
mean Body mass index was 25 kg/m2 + 3.7. Troponin levels at 4 
days post-infarction were 0.65 ng/ml + 0.8 while at the control 
exam on 6 weeks were 0.24 ng/ml + 0.4. Pro-BNP levels at 4 days 
were 696.0 pg/ml + 404 and at 6 weeks showed an improvement 
to a level of 547 0 pg/ml + 281 (Table 4). 
 
 
 
 
 
 
 
 
 
 
      
Table 3 . Demographics of patients who were enrolled in the study. ACS (Acute 
coronary syndrome) . PCI ( percutaneous coronary intervention) 
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Table 4 . Mean and standard deviation of Age, Body mass index (BMI), Ejection fraction (EF), Global and 
regional strain rate at rest and under stress (SR-Rest, SR-Stress) at 4 days and 6 weeks, Troponin levels at 4 
days and 6 weeks and  Pro-Brain Natriuretic Peptide at 4 days and 6 weeks.  
 
  
 
     Gender difference was not significant in both global and 
regional, resting and stress strain obtained with speckle tracking 
neither at 4 days nor at 6 weeks, p value > 0.5. Hypertension was 
a significant factor in determining global stress strain rate at 4 
days, p value 0.16, while it did not have any significance at 
resting and stress strain at 6 weeks. Diabetes mellitus (DM) was 
highly significant in affecting global strain rate at rest and at 
stress on 4 days, p value 0.017 and 0.001 respectively. At 6 
weeks follow up, DM was not significant at rest or at stress. Both 
smoking and Hyperlipidemia have not shown any significance in 
relation to global and regional, resting and stress strain obtained 
with speckle tracking. Throughout the patients who had a 
previous ACS showed significance in affecting global stress strain 
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at 6 week, p value 0.3. The patients with previous stenting had 
significantly lower global and regional strain rate at stress at 
both 4 days and 6 weeks in comparison to patients with no 
history of PCI, p value 0.02 and 0.12 respectively. The 
significance of such values were determined on the basis of 
improvement or worsening the strain rate values in resting and 
stress studies at 4 days and at 6 weeks of follow up.  
 
    Age and BMI were not significant to affect global stress strain, 
whether as an improvement or worsening, at the performed 
follow up study at 6 weeks. Whereas Troponin showed a 
significance of predicting the worsening of stress strain values at 
the follow up with a p value of 0.005. Pro-BNP level had also 
shown a statistical significance in detecting the global stress 
strain outcome at 6 weeks with a p value of 0.2 (Figure 12).  
Figure 12 . Mean values of Age, BMI, Troponin at 4 days and 6 weeks 
and ProBNP at 4 days and 6 weeks in a comparison based on 
improvement and worsening the global stress strain values.  
 
 
    Based on the same concept, Age and BMI were not significant 
in determining the positive or negative regional stress strain 
outcome at 6 weeks. While Troponin had shown a statistical 
significance in predicting the negative regional outcome with a p 
value of 0.13. Pro-BNP was also significant in determining the 
regional stress strain outcome at 6 weeks with a p value of 0.43.  
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    Troponin levels at 6 weeks showed a moderate correlation 
with global stress strain obtained with speckle tracking at 6 
weeks with r value of  0.43 and p value <0.001. ProBNP exhibited 
a moderate correlation with global stress strain obtained with 
speckle tracking at 6 weeks with r value of 0.41 and p value of 
0.003 (Figure 13 and figure 14).  
 
Figure 13.Correlation between Troponin levels and global stress strain 
at 6 weeks.  
 
 
Figure 14.  Correlation between ProBNP levels and global stress strain 
at 6 weeks.  
 
     Meanwhile, Troponin values at 6 weeks showed a strong 
correlation with regional stress strain rate at 6 weeks  with a r 
value of 0.64 and p value <0.001. ProBNP levels at 6 weeks 
indicated a strong correlation as well with regional stress strain 
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at 6 weeks with a r value of 0.66 and p value <0.0001 (Figure 15 
and 16).  
                                                                                                                                                    
 
 
Figure 15.Correlation between Troponin levels at 6 weeks and regional 
stress strain at 6 weeks.  
 
 
Figure 16.  Correlation between ProBNP levels at 6 weeks and regional 
stress strain at 6 weeks.  
 
    A statistical agreement was conducted to detect the most 
appropriate method in determining post-infarction ischemia at 4 
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days in relation to cardiac MRI at the different level of 
myocardial walls. Dobutamine stress echocardiography revealed 
a kappa value of 0.72 with a p value of 0.04 while global strain 
rate at rest showed a kappa value of  0.79 with a p value of 0.006. 
Global strain rate under stress had a kappa value of 0.89 with a p 
value of 0.0001 (Figure 17). 
 
Figure  17.  Agreement analysis at 4 days comparing different 
echocardiographic methods to cardiac MRI in detecting post-MI 
ischemia.  
 
    Moreover, the same analysis was performed to distinguish the 
different echocardiographic data obtained through dobutamine 
stress, resting strain rate and stress strain rate at 4 days in 
correlation to the ischemic territory in coronary angiography. In 
this analysis an agreement was found between wall motion 
analysis revealed by dobutamine stress echocardiography with 
kappa value of 0.25 and p value of 0.1. Using resting strain 
revealed an agreement with a kappa value of 0.32 and p value of 
71 
 
0.04. Obtaining strain rate at stress raised the agreement to a 
kappa value of 0.46 with a p value of 0.001( Figure 18).  
 
 
Figure 18.  Agreement analysis at 4 days comparing different 
echocardiographic methods to coronary angiography findings in detecting 
post-MI ischemia.  
 
    Global stress strain rate obtained from speckle tracking 
showed different levels in relation to the MI extent at 6 
weeks. A sub-endocardial MI (<50% extension of left 
ventricular wall as measured by cardiac MRI) had a mean 
value of   -18,9+ 4.8 while a non-transmural infarction 
(50%-90% extension of left ventricular wall) showed a 
mean value of -9.6 + 5.2. On the other hand, a transmural 
infarction (100% involvement of left ventricular wall) 
indicated a mean value of -4.9+ 4.4. (Figure 19). 
 
Figure 19. Mean values and standard deviation of global stress strain 
obtained by speckle tracking as differentiated by extent of infarction in 
cardiac MRI.  
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    Regional stress strain rate at 6 weeks also was able to 
discriminate various forms of myocardial infarction extension 
through left ventricular wall with a mean value of -19.5 +3.9 in 
sub-endocardial infarction. In non-transmural MI, a mean value 
of regional stress strain of -12.1+5.2 was detected. Furthermore 
a mean value of -1.9+2.5 was demonstrated in patients with 
transmural MI (Figure 20). 
 
Figure 20. Mean values and standard deviation of regional stress strain 
obtained by speckle tracking as differentiated by extent of infarction in 
cardiac MRI.  
 
    We conducted a Receiver-operating characteristics (ROC 
analysis)in order to detect the sensitivity and specificity of 
various diagnostic modus obtained from echocardiography 
(normal stress echocardiography, resting strain stress obtained 
by speckle tracking and speckle tracking stress strain stress)   in 
relation to cardiac MRI viability.  
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      It revealed a 60% sensitivity and 74.29% specificity while 
applying wall motion abnormalities detected by dobutamine 
stress echocardiography ( AUC, Area under the curve 0,677) 
Figure 21. 
  
Figure 21. Sensitivity and specificity of dobutamine stress in detecting 
viability at 6 weeks in comparison with cardiac MRI.  
 
    Global resting strain rate was 74.09% sensitive and 60% 
specific in detecting myocardial viability in relation to cardiac 
MRI (AUC 0.764) at a cut-off value of -10.4 in differentiating 
transmural from non-transmural infarction and a cut-off value -
17.65 differentiating subendocardial from non-transmural 
infarction. Figure 22.  
 
Figure 22 
Sensitivity and 
specificity of 
resting strain 
rate obtained 
by speckle 
tracking in 
detecting 
viability at 6 
weeks in 
comparison 
with cardiac 
MRI.  
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     Obtaining strain rate under stress by speckle tracking 
provided a 81.82% sensitivity and 82.6% specificity to detect 
transmural from non-transmural infaction at a cut-off value of -
10.15. Meanwhile it carried a 76.92% sensitivity and 79% 
specificity to detect sub-endocardial from non-transmural 
infarction at a cut-off value of -18. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23:  Sensitivity and specificity of stress strain rate obtained by 
speckle tracking in detecting viability at 6 weeks in comparison with 
cardiac MRI 
 
       We performed a multivariate regression analysis to find the 
best method for detecting myocardial viability at 6 weeks, using 
Cardiac MRI as the reference method. That disclosed a regression 
coefficient of 0.182 with significance level of p value 0.0022 as of 
using dobutamine stress in detecting viability. Utilization of 
regional strain rate showed a regression coefficient of 0.168 with 
a p value of 0.0034. A regression of 0.501 with a significance 
level of <0.0001 was raised by using global strain rate at rest 
(Figures 24,25).  
75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure24. regression analysis of wall motion abnormality detected by 
dobutamine stress in myocardial viability in relation to cardiac MRI. 
 
 
 
 
 
Figure 25. regression analysis of regional strain rate values at rest in 
myocardial viability in relation to cardiac MRI. 
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     Regional strain rate values under stress divulged a highly 
significant regression with a coefficient of 0.776 and a p value 
<0.0001. While the highest significance was obtained by global 
stress strain rate with a regression coefficient of 0.8 and a 
significance level of <0.0001.  Figures 26,27,28. 
 
Figure 26. regression analysis global strain rate at rest in assessing 
myocardial viability in relation to cardiac MRI. 
 
 
Figure 27. regression analysis of regional stress strain rate in evaluating  
myocardial viability in relation to cardiac MRI. 
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Figure 28. regression analysis of global strain rate speckle tracking under 
dobutamine stress in myocardial viability in relation to cardiac MRI. 
 
   A one year follow up of the patient perceived a 4 cases of 
hospital re-admission due to cardiology-related symptoms ( 2 
patients with recurrent chest pain, one patients dyspnea on mild 
exertion NYHA III and one patient with cardiac syncope). Global 
stress strain rate obtained from speckle tracking showed 80% 
sensitivity and 77.5% specificity at a cut-off value of -9.1 to 
predict hospital re-admission  (Figure 29). 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Predicting hospital re-admission from stress speckle 
tracking  
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     From those 4 patients, two were diagnosed with acute 
coronary syndrome depending on the laboratory findings and 
ECG changes (one patient with unstable angina pectoris and one 
patient with NSTEMI). A cut-off value of -8.4 had shown a 
69.23% sensitivity and 73.5% specificity to predict the 
recurrence of acute coronary syndrome (Figure 30). 
 
 
 
 
 
Figure 30. Predicting recurrence of acute coronary syndrome events 
from stress speckle tracking.  
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Case I. 
Figure 31. Stress speckle tracking 6 weeks after STEMI revealing 
a massive transmural involvement of anterior wall . Cardiac MRI 
on the same day revealing same results and confirming the 
speckle data. The cardiac function didn’t improve and the patient 
received primary prophylactic ICD as a result of ischemic 
cardiomyopathy. 
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Case II.                                                                                                                                                                     
Figure 32.  Stress speckle tracking showing moderate 
involvement of lateral myocardial wall 6 weeks after PCI of LCX 
lesion presenting with STEMI. In cardiac MRI a non-transmural 
involvement of myocardium of the lateral wall could be seen.  
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Discussion 
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     Forty nine patients were enrolled from Mai 2013 until 
December 2014 from the coronary care unit (CCU) at Coburg 
hospital. The Patients were diagnosed with ST elevation 
myocardial infarction patients based on their ECG, laboratory 
findings and symptoms at admission. A follow up study was 
undertook at 6 weeks after STEMI. 
 
    They were examined with echocardiography at rest and at low 
dobutamine stress on 4 days and at rest and high dobutamine 
stress on 6 weeks to determine the global and regional strain 
rate values. All patients were evaluated through cardiac MRI as a 
gold standard method of determining myocardial viability at 4 
days and 6 weeks as well. 
 
    The results as shown in chapter 5 have revealed a powerful 
and promising role of utilization of stress speckle tracking 
whether as an evaluating tool for post-myocardial infarction 
viability assessment or as an effective risk stratification value 
just before hospital discharge after STEMI. The obtained stress 
strain rate from speckle tracking have correlated with cardiac 
MRI as gold standard method.  
 
     A Norwegian experimental study, which took place in 2010 
tried to simulate a clinical stress test applied in coronary artery 
disease with a constant coronary stenosis of about 80%, causing 
a 35% flow reduction at rest. This level of experimental stenosis, 
allowing flow reserve during dobutamine application combined 
with hypoperfusion, was crucial in obtaining the increased 
deformations during the inotropic challenge. Assami et al, 2010 
 
    The study demonstrated that the spatial sensitivity of the 
speckle tracking high-resolution ultrasound allows a focused 
assessment of specific layers of the myocardium and a graded 
assessment of parts of the myocardial wall with a different 
sensitivity to reduced coronary reserve. Thus, when applying an 
inotropic challenge to the hypoperfused ventricular wall, the 
mid-myocardial layers in longitudinal and circumferential 
directions demonstrated the highest sensitivity by increasing the 
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deformation measured by ET strain. This heterogeneous 
response was also evident by the lack of response of 
subendocardial and midendocardial radial ET strain. This 
observation is compatible with previous studies Jamal F et al, 
2001, as sub-midendocardial radial ET strain might need cross-
fiber activation of all layers and therefore might not be 
significantly activated when not all myocardial layers normalize 
their contractility. Rademakers et al, 1994 
 
    Hong Ran et al evaluated in 2012 whether myocardial strain 
under adenosine stress calculated from two-dimensional 
echocardiography by automatic frame-by-frame tracking of 
natural acoustic markers enables objective description of 
myocardial viability in clinic.  
 
  Two-dimensional echocardiography and two-dimensional 
speckle tracking imaging (2D STI) at rest were performed first 
and once again after adenosine was infused at 140 ug/kg/min 
over a period of 6 minutes in 36 stable patients with previous 
myocardial infarction. Hong Ran et al, 2012 
 
    Radionuclide myocardial perfusion/metabolic imaging served 
in his study as the “gold standard” to define myocardial viability 
was given in all patients within 1 day. Two-dimensional speckle 
tracking images were acquired at rest and after adenosine 
administration. 
 
    An automatic frame-by-frame tracking system of natural 
acoustic echocardiographic markers was used to calculate 2D 
strain variables including peak-systolic circumferential strain 
(CS peak-sys), radial strain (RS peak-sys), and longitudinal strain 
(LS peak-sys). Hong Ran et al, 2012 
 
      Accordingly, in nonviable group strain values showed no 
significant changes during adenosine administration. After 
adenosine administration, RS peak-sys and LS peak-sys in viable 
group increased significantly compared with nonviable group. 
Obtained strain data were highly reproducible and affected in 
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small intra-observer and inter-observer variability. A change of 
radial strain more than 9.5% has a sensitivity of 83.9% and a 
specificity of 81.4% for viable whereas a change of longitudinal 
strain more than 14.6% allowed a sensitivity of 86.7% and a 
specificity of 90.2%. Hong Ran et al, 2012 
 
    In 2005, longitudinal strain was evaluated to determine the 
value of regional deformation when compared to cardiac MRI. 
SRs and SRe were significantly lower in subendocardial 
infarction compared with normal myocardium. Moreover, they 
established a direct relationship between SRI, transmurality, and 
infarct size. Linear regression analysis showed that both SRs and 
Sm of the infarct area had a significant correlation with the 
infarct size. SRs of the transmural infarcted segments were 
significantly decreased when compared with non-transmural, 
subendocardial MI, and normal segments; SRs and SRe were also 
significantly reduced in subendocardial infarction compared 
with normal subjects. Zhang et al, 2005 
 
  In a correlative functional/histo-pathologic closed-chest animal 
study, it was shown that SRs and strain could also clearly 
differentiate non-transmural from transmural infarction. 
Weidemann et al, 2003 
 
    Standard Strain rate analysis, demands manual tracing of the 
myocardium whereas automated function imaging (AFI) offers 
more convenient (based on selection of three points) assessment 
of longitudinal strain. Nevertheless, feasibility and correlation 
between both methods were not thoroughly examined until 
2014, especially during tachycardia at peak stage of dobutamine 
stress echocardiography (DSE).  
 
     A polish study assessed correlations between STE and AFI 
derived peak systolic longitudinal strain values for global and 
regional parameters, feasibility, time of analysis and inter-
observer agreement. The novel, simplified AFI technique offered 
similar feasibility, lower coefficient of variance both during rest 
and peak stress stage significantly (about two times) shorter 
time needed for analysis. Wierzbowska et al, 2014 
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   However, investigating strain Doppler echocardiography 
performed immediately after revascularization by percutaneous 
coronary intervention predicted the extent of myocardial scar, 
determined by contrast-enhanced magnetic resonance imaging. 
Vartdal et al, 2007  
 
   A good correlation was found between the global strain and 
total infarct size (R 0.77, p< 0.00001). A multi-variate regression 
analysis showed that global peak strain and serum glutamic 
oxaloacetic transaminase correlated with the infarct size 
measured by MRI (p <0.0001 and p < 0.001, respectively). 
Furthermore, a clear inverse relationship was found between the 
segmental strain and the transmural extent of infarction in each 
segment. Vartdal et al, 2007 
 
  The authors concluded that global strain parameter is a 
valuable predictor of the total extent of myocardial infarction 
and may therefore be an important clinical tool for risk 
stratification in the acute phase of myocardial infarction. 
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Limitations 
 
 
 
 
 
1- Heart rate variability played a negative role in 
strain rate offline analysis. The analysis was aborted and 
many patients were therefore excluded from the study. 
Patients with atrial fibrillation were as well excluded as 
the program couldn’t overcome the heart rate variability 
during the study.  
 
2- Failure of obtaining a perfect acoustic window 
during performing the echocardiography remains a 
critical limitation in markedly obese patients or hyper-
inflated thoracic wall.  
 
3- Single center study with relatively limited number 
of studied objects.  
 
4- Patients with pacemakers, central nervous system 
aneurysm clips, cochlear implants, implanted neural 
stimulator or patients with insulin pump were not 
appropriate to be examined through cardiac MRI. 
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Conclusion 
 
 
 
 
 
   Strain rate obtained from speckle tracking during stress is a 
powerful method of detecting myocardial viability after STEMI 
and provide dependable results in comparison to strain rate 
obtained at rest.   
 
   It’s safe, fast and reproducible. It elucidates the Inter- and 
Intra-observer variability of normal stress echocardiography.  
 
   It is a highly sensitive and specific test in correlation to the gold 
standard method (cardiac MRI).  
 
   Moreover, it carries a promising role in post-myocardial 
infarction risk stratification with a reasonable prediction of 
reversible coronary events or hospital re-admission.  
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Recommendations 
 
 
 
 
    Performing stress echocardiography with a parallel obtaining 
of strain rate through speckle tracking 96 h after myocardial 
infarction and at 6 weeks is important to detect both risk 
stratification and viability. 
 
   Conducting a multi-centric study for more data validation and 
eventually applying the data in the appropriate guidelines 
criteria.  
 
   Conducting the study with a large number of patients will help 
to overcome the limitation of statistical accuracy at low number 
data. 
 
   Encouraging the manufacturing companies of 
echocardiography machines to provide a solution for heart rate 
variability problems through offline processing and analysis. 
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